nsv5665203
- Organism: Homo sapiens
- Study:nstd207 (Ebert et al. 2021)
- Variant Type:inversion
- Method Type:Optical mapping, Sequencing
- Submitted on:GRCh38
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:19,756
- Publication(s):Ebert et al. 2021
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 204 SVs from 48 studies. See in: genome view
Overlapping variant regions from other studies: 204 SVs from 48 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nsv5665203 | Submitted genomic | GRCh38 (hg38) | Primary Assembly | NC_000002.12 | Chr2 | 113,578,563 | 113,598,318 | ||
| nsv5665203 | Remapped | Perfect | GRCh37.p13 | Primary Assembly | First Pass | NC_000002.11 | Chr2 | 114,336,140 | 114,355,895 |
Variant Call Information
| Variant Call ID | Type | Sample ID | Method | Analysis | Other Calls in this Sample and Study |
|---|---|---|---|---|---|
| nssv17108214 | inversion | SAMN00006579 | Optical mapping, Sequencing | Optical mapping, Sequence alignment | 23,265 |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nssv17108214 | Submitted genomic | NC_000002.12:g.113 578563_113598318in v | GRCh38 (hg38) | NC_000002.12 | Chr2 | 113,578,563 | 113,598,318 | ||
| nssv17108214 | Remapped | Perfect | NC_000002.11:g.114 336140_114355895in v | GRCh37.p13 | First Pass | NC_000002.11 | Chr2 | 114,336,140 | 114,355,895 |